News|Articles|February 14, 2008

Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

Author(s)Pharmaceutical Technology Editors

Chesapeake to relocate and expand, AVI BioPharma appoints CEO, More...

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025

ByPatrick Lavery

December 15th 2025

Facsimile Amoxicillin Prescription | Image Credit: © Sherry Young - stock.adobe.com

FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis

ByPatrick Lavery

December 12th 2025

PharmTech Weekly News Roundup – Week of December 8, 2025

ByPatrick Lavery

December 12th 2025

Europa medicada | Image Credit: ©Parato -stock.adobe.com

EMA Calls New EU Pharma Legislation Most Significant in Two Decades

BySusan Haigney

December 12th 2025

European Union Health Concept | Image Credit: ©xtock -stock.adobe.com

European Parliament Revamps Pharmaceutical Policy Framework

BySusan Haigney

December 11th 2025

Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

Newsletter

Related Content

FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025

FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis

PharmTech Weekly News Roundup – Week of December 8, 2025

EMA Calls New EU Pharma Legislation Most Significant in Two Decades

European Parliament Revamps Pharmaceutical Policy Framework

Trending on Pharmaceutical Technology

EMA Calls New EU Pharma Legislation Most Significant in Two Decades

FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis

European Parliament Revamps Pharmaceutical Policy Framework

PharmTech Weekly News Roundup – Week of December 8, 2025

Indivumed, URMC Launch Joint Venture for Patient-Centric Cancer R&D